XPN ProbioSix 20B
Natural health product licensed in Canada
- Other names
- Martin Allard Nutraceutique Probiotique Control, ProBio MAX, Probios Believe
- Licence holder
- Supplements K.D. Inc.
- NPN or DIN-HM
- 80074895
- Status
- Active licence
- Licence date
- 10 January 2017
- Revision date
- 17 February 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum subsp. longum Source : Cellule entière | 3 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : A027 | 3 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : HA-108 | 0.8 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Cellule entière | 0.8 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : A104 | 1.82 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 1.82 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : HA-194 | 5.5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 5.5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 8 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : A041 | 8 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 1.5 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : A193 | 1.5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Gélatine, Vitamine C, Inuline, Cellulose, Fructooligosaccharides, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Contribue à soutenir la santé gastrointestinale. Pourrait promouvoir une flore intestinale saine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vous souffrez de fièvre, de vomissements, de diarrhée sanglante ou de douleurs abdominales intenses, consulter un praticien de soins de santé avant d'en faire l'usage. Si des symptômes de troubles digestifs (p. ex. diarrhée) se manifestent, s'aggravent et/ou persistent au-delà de 3 jours, cesser l'utilisation et consulter un praticien de soins de santé. Si vous êtes allergique aux produits laitiers, ne pas utiliser ce produit.
- Contre-indications
Si vous souffrez d¿un déficit immunitaire (p. ex. sida, lymphome, patients subissant un traitement prolongé aux corticostéroïdes), ne pas utiliser ce produit.
Source
Official Health Canada record, licence 80074895
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.